Company intelligence / Profile preview

Auson Pharmaceuticals

Shanghai, Shanghai, Chinadockets.justia.com ↗

Ownership: Private
Employees: ~9
Development stage: Other

Overview

Auson Pharmaceuticals is a China-based biopharma company focused on developing and commercializing innovative drugs for vascular diseases and anti-virus indications. The company leverages specialty technology to address unmet medical needs, primarily through new dosage forms, new indications, and optimized dosing regimens. Its lead programs include a timolol maleate gel for topical administration (approved elsewhere) and ASN008 targeting sodium channels for hepatitis B in Phase 1 trials. The company also pursues niche generics using the US FDA 505(b)(2) pathway and China's class 2 drug registration route.

Therapeutic areas: OphthalmologyOncologyInfectious Diseases
Modalities: Small moleculeChemical drugs
Industry: Biotech

Beyond the preview

Go deeper on Auson Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Auson Pharmaceuticals.

Explore the full profile